Drug Profile
Non-Hodgkin's lymphoma vaccine - XEME Biopharma
Alternative Names: B-cell lymphoma vaccine - XEME Biopharma; Follicular lymphoma vaccine - XEME Biopharma; Oncoquest-L; Oncoquest-L vaccineLatest Information Update: 18 Dec 2023
Price :
$50
*
At a glance
- Originator XEME Biopharma
- Class Cancer vaccines
- Mechanism of Action Cytotoxic T lymphocyte stimulants; Natural killer cell stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Non-Hodgkin's lymphoma
Most Recent Events
- 08 Oct 2020 Seattle Genetics is now called Seagen
- 28 Mar 2019 No recent reports of development identified for phase-I development in Non-Hodgkin's-lymphoma in USA (SC, Injection)
- 09 Mar 2018 Cascadian Therapeutics has been acquired by Seattle Genetics